Q1 2024 Holdings
Filed 2024-05-15 | 261 holdings | $440.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $35.0M | 234,400 | 7.9% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $33.9M | 318,120 | 7.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $29.4M | 2,791,870 | 6.7% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $27.2M | 52,000 | 6.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $26.9M | 180,145 | 6.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $22.7M | 785,655 | 5.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $22.4M | 319,510 | 5.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $22.4M | 338,243 | 5.1% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $21.9M | 721,301 | 5.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $17.0M | 549,804 | 3.9% |
| Merrimack Pharmaceuticals in(MACKEUR) | COM NEW | 590328209 | $13.3M | 902,350 | 3.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.3M | 48,584 | 1.7% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $5.4M | 2,074,183 | 1.2% |
| Avrobio Inc | COM | 05455M100 | $5.1M | 3,954,857 | 1.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $4.9M | 31,505 | 1.1% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $4.4M | 10,000 | 1.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.2M | 156,600 | 1.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.2M | 403,500 | 1.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.0M | 31,105 | 0.9% |
| Endeavor Group Hldgs Inc(0C3) | CL A COM | 29260Y109 | $4.0M | 155,250 | 0.9% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $4.0M | 875,000 | 0.9% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $3.8M | 177,200 | 0.9% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.3M | 586,984 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.3M | 180,911 | 0.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.2M | 339,825 | 0.7% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $3.2M | 187,567 | 0.7% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $3.1M | 456,588 | 0.7% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $3.0M | 32,500 | 0.7% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.0M | 106,342 | 0.7% |
| Vanguard BD Index FDS(VUSB) | VANGUARD ULTRA | 92203C303 | $2.7M | 55,206 | 0.6% |
| J P Morgan Exchange Traded F(JPST) | ULTRA SHRT INC | 46641Q837 | $2.7M | 54,000 | 0.6% |
| Ishares TR(SHV) | SHORT TREAS BD | 464288679 | $2.7M | 24,500 | 0.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.7M | 203,204 | 0.6% |
| Wisdomtree TR(USFR) | FLOATNG RAT TREA | 97717Y527 | $2.7M | 53,000 | 0.6% |
| Cellectar Biosciences Inc(CLRBUSD) | COM NEW | 15117F807 | $2.6M | 642,541 | 0.6% |
| Omniab Inc(OABI) | COM | 68218J103 | $2.4M | 451,485 | 0.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.3M | 206,856 | 0.5% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.2M | 2,300 | 0.5% |
| Ibio Inc(IBIO) | CON NEW | 451033708 | $2.2M | 600,000 | 0.5% |
| Corteva Inc(CTVA) | COM | 22052L104 | $2.2M | 37,400 | 0.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR)Put | COM | 15678U128 | $2.1M | 50,200 | 0.5% |
| Beyond AIR Inc | COM | 08862L103 | $2.1M | 1,204,820 | 0.5% |
| Guardant Health Inc(GH)Call | COM | 40131M109 | $2.1M | 100,000 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.0M | 60,763 | 0.4% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $2.0M | 26,800 | 0.4% |
| SSgA Active ETF TR(ULST) | ULT SHT TRM BD | 78467V707 | $1.9M | 47,684 | 0.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.9M | 49,500 | 0.4% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $1.7M | 63,586 | 0.4% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $1.7M | 11,200 | 0.4% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $1.6M | 926,929 | 0.4% |